Results 131 to 140 of about 33,357 (182)

Safety and effects of anti-obesity medications on weight loss, cardiometabolic, and psychological outcomes in people living with overweight or obesity: a systematic review and meta-analysis. [PDF]

EClinicalMedicine
Liu L, Li Z, Ye W, Peng P, Wang Y, Wan L, Li J, Zhang M, Wang Y, Liu R, Xu D, Zhang J.   +11 more
europepmc   +1 more source

Tolerance of Bupropion SR After Delayed-Onset Urticaria and Angioedema Associated With Bupropion XL. [PDF]

Case Rep Psychiatry
Elali FR, Grant AC.
europepmc   +1 more source

Interindividual variability in the prevalence of OPRM1 and CYP2B6 gene variations may identify drug-susceptible populations [PDF]

, 2011
Bunten, Hannah, Liang, Wei-Jun, Osselton, David M., Pounder, Derrick   +3 more
core  

Delayed allergic reaction from bupropion in a 27-year-old male with MDD: A case report and literature review. [PDF]

Ment Health Clin
Anghel A, Wilkening GL.
europepmc   +1 more source

Effectiveness of Extended-Release Bupropion and Duloxetine on Pelvic Pain and Sexual Function among Patients with Chronic Prostatitis/Chronic Pelvic Pain. [PDF]

Adv Biomed Res
Jaafari S, Molaeinezhad M, Tarrahi MJ, Moosaei MR, Sahfiei K, Afshar H.   +5 more
europepmc   +1 more source

Real-world efficacy and safety of naltrexone-bupropion therapy in Chinese patients with obesity: A single-centre experience. [PDF]

Endocrine
Lui DTW, Tsoi KH, Fong CHY, Jiang NS, Chow WS, Yuen MMA.   +5 more
europepmc   +1 more source

Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults.

JAMA Health Forum
Hwang JH, Laiteerapong N, Huang ES, Kim DD.   +3 more
europepmc   +1 more source